Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
November 20, 2015
As Natural Products INSIDER reported earlier this fall, FDA has revealed that a number of dietary supplement companies are still failing to establish specifications and test ingredients. Clearly, regulators find intolerable such deviations from the cGMPs (current Good Manufacturing Practices). But an FDA official recently highlighted cGMP data that gives the industry—particularly larger companies—reason for optimism. And an Herbalife executive provided context for understanding the significance of FDA "observations" following a cGMP inspection.
You May Also Like
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024
Formulating the future: The industry may not be ready for AI in product development, and AI might not be ready for the industry, eitherFeb 20, 2024
Beyond the primary outcome: How exploratory analysis can deliver unexpected new insightsFeb 19, 2024
Survey shows dietitians concerned about TikTok misinformationFeb 16, 2024